Virtu Financial LLC

Position in AVXL — Anavex Life Sciences Corp.

CIK 1533964 New York, NY

Position in AVXL

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$63,269

-$51,176 QoQ

Shares Held

20,609

+60.3% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Virtu Financial LLC holds $51,538,389 across 141 Biotechnology names. AVXL ranks #92 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TERN	Terns Pharmaceuticals, Inc.	70,715	$3,728,094
2	VRTX	Vertex Pharmaceuticals Inc / Ma	7,634	$3,408,886
3	CNTA	Centessa Pharmaceuticals plc	67,775	$2,692,023
4	APLS	Apellis Pharmaceuticals, Inc.	54,785	$2,204,000
5	BMRN	Biomarin Pharmaceutical Inc	38,479	$2,173,678
6	IBRX	ImmunityBio, Inc.	262,298	$2,011,825
7	KALA	KALA BIO, Inc.	152,197	$1,316,504
8	IMUX	Immunic, Inc.	113,366	$1,258,362

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$63,269	20,609	+60.3%	Shares	Defined	2026-05-14
2025-09-30	$114,445	12,859	-50.3%	Shares	Defined	2025-11-14
2025-03-31	$222,179	25,895	-71.2%	Shares	Defined	2025-05-12
2024-12-31	$966,965	90,034	+121.7%	Shares	Defined	2025-02-11
2024-03-31	$206,715	40,612	+87.5%	Shares	Defined	2024-05-20
2023-12-31	$201,635	21,658	+88.2%	Shares	Defined	2024-02-26
2023-06-30	$93,551	11,507	-83.2%	Shares	Defined	2023-07-27
2023-03-31	$585,888	68,365	+130.9%	Shares	Defined	2023-05-01
2022-12-31	$274,225	29,614	+90.8%	Shares	Defined	2023-02-15
2021-12-31	$269,168	15,523	-80.8%	Shares	Defined	2022-02-17
2021-06-30	$1,851,911	81,011	+438.3%	Shares	Defined	2021-09-17
2020-12-31	$81,270	15,050	-51.1%	Shares	Defined	2021-02-24
2020-09-30	$139,894	30,746	+138.3%	Shares	Defined	2020-12-11
2020-06-30	$63,482	12,903	—	Shares	Defined	2020-08-07
No filing history on record for this holder in this stock.